Are International Markets Worth Investing In for U.S. Investors?

The article argues that U.S. equities remain strong but that investors should consider allocating 5% of portfolios to the Vanguard Total International Stock ETF (VXUS) for geographic diversification. It highlights the S&P 500’s 305% total return over the past decade and notes VXUS’s low 0.05% expense ratio and top holdings in Taiwan Semiconductor, Samsung Electronics, and ASML. The piece is primarily a portfolio-positioning and valuation commentary, not a company-specific catalyst.

Analysis

The real second-order effect here is not “international beats the U.S.”; it is a rotation in where global factor premiums get harvested. If U.S. mega-cap concentration cools, the first beneficiaries are the biggest foreign index weights with hard industrial moats and direct AI/supply-chain leverage—TSM, ASML, and to a lesser extent Samsung—because VXUS packages that exposure cheaply without forcing a single-country bet. That makes the wrapper attractive even if the thesis is really a narrow bet on semis and capex rather than broad ex-U.S. alpha.

The market is implicitly treating U.S. exceptionalism as durable, so the contrarian opportunity is less about being bearish America and more about owning neglected duration outside the U.S. at a discount. A 5% allocation is small enough to be politically easy for institutions, but large enough to matter if the next 12-24 months bring a softer dollar, more trade friction, or multiple compression in U.S. growth stocks. In that setup, the biggest relative winners are foreign cyclicals and global suppliers tied to AI infrastructure, while pure domestic U.S. compounders face a higher hurdle rate.

BRK.B is the cleanest hedge inside the listed names: it benefits if U.S. leadership broadens and valuation discipline matters again, while avoiding the frothier end of the growth spectrum. NVDA remains structurally strong, but any international re-rating that favors non-U.S. semiconductor capacity could cap multiple expansion as supply-chain localization gains political support. NFLX is basically irrelevant to the article’s thesis, which itself is a useful signal: this is not a broad risk-on call, but a narrow allocation argument that could be over- or under-owned depending on how much global investors already have hidden foreign exposure through U.S.-listed multinationals.

Key Decisions for Investors

• Go long VXUS on a 3-6 month horizon as a cheap diversification sleeve; target 5% portfolio weight with a 10-15% relative outperformance hurdle versus SPY before trimming.
• Pair trade: long TSM / short a U.S. mega-cap basket (e.g., equal-weighted NVDA+MSFT+AVGO proxy) for 6-12 months to express the view that AI capex leadership migrates to the supply chain rather than the demand side.
• Add ASML on pullbacks as a 12-18 month secular hold; risk/reward improves if U.S. valuation compression continues and European industrial tech re-rates from depressed multiples.
• Use BRK.B as the defensive long inside U.S. equities; it should outperform if the market rotates from long-duration growth into cash-generative, lower-multiple compounders over the next two quarters.
• Avoid initiating fresh NFLX exposure as a thesis vehicle here; it has limited direct linkage to the international-diversification trade and offers poor signal-to-noise for this macro setup.